Terryson personal page - To The Moon

Terryson

Terryson

No personal profile

21Follow

0Followers

0Topic

0Badge

2021-08-26

Good

Sorry, the original content has been removed

2021-06-02

Up

Singapore Allows Sinovac Vaccine After WHO Emergency Approval

2021-06-02

Up

Sorry, the original content has been removed

2021-03-30

Ermmm

Sorry, the original content has been removed

2021-03-30

It is time to pay attention to Oil & Gas

Oil prices hit by wave of hedge fund profit-taking: Kemp

2021-03-30

Finally

Oil prices slip as focus switches from Suez Canal blockage to OPEC+ supply policy

2021-03-30

Alert

Beware The 11 Most Overvalued Stocks Now, Analysts Warn

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3574939326528857","uuid":"3574939326528857","gmtCreate":1611845630923,"gmtModify":1629982020205,"name":"Terryson","pinyin":"terryson","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":21,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":810235187,"gmtCreate":1629979573749,"gmtModify":1676530190421,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/810235187","repostId":"2162099674","repostType":4,"isVote":1,"tweetType":1,"viewCount":817,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574771607647825","authorId":"3574771607647825","name":"Eellen","avatar":"https://static.tigerbbs.com/0cbc0a268b9b34bfdb5dbf82ce98d474","crmLevel":3,"crmLevelSwitch":1,"idStr":"3574771607647825","authorIdStr":"3574771607647825"},"content":"Like and comment","text":"Like and comment","html":"Like and comment"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113702277,"gmtCreate":1622638243499,"gmtModify":1704187801818,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/113702277","repostId":"1132140510","repostType":4,"repost":{"id":"1132140510","kind":"news","pubTimestamp":1622637521,"share":"https://ttm.financial/m/news/1132140510?lang=&edition=fundamental","pubTime":"2021-06-02 20:38","market":"us","language":"en","title":"Singapore Allows Sinovac Vaccine After WHO Emergency Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1132140510","media":"Bloomberg","summary":"Singapore will allow the use of Sinovac Biotech Ltd.’s Covid-19 vaccine, after the World Health Orga","content":"<p>Singapore will allow the use of&nbsp;Sinovac Biotech Ltd.’s Covid-19 vaccine, after the World Health Organization approved the drug as part of its emergency use listing.</p>\n<p>The move means the drug can be administered by private health care providers as part of a program that allows the use of unregistered Covid-19 vaccines, the ministry of health said in a statement Wednesday. The Sinovac vaccine is not part of the national vaccine program.</p>\n<p>The World Health Organization&nbsp;authorized&nbsp;the Sinovac vaccine on June 1, paving the way for a wider rollout in countriesscramblingfor a supply of immunizations. Singapore’s decision comes about three months after the country received its&nbsp;first shipment&nbsp;of&nbsp;200,000 doses&nbsp;of the Sinovac shot on Feb. 23, and amid&nbsp;debate&nbsp;over the efficacy of the vaccine.</p>\n<p>The shot, dubbed CoronaVac, has the lowest efficacy rate reported from clinical trials among the frontrunner wave of vaccines: it was found to be just 50.7% effective in preventing symptomatic Covid in a trial in Brazil, barely crossing the minimum threshold required by drug regulators around the world. But real world evidence is emerging that it’s far more effective on the ground: In a&nbsp;recent study&nbsp;of around 130,000 Indonesia health workers, it protected 94% against symptomatic infection, 96% against hospitalization, and 98% against death.</p>\n<p>Singapore has authorized both the Pfizer Inc.-BioNTech SE and Moderna Inc. vaccines, and has one of the best per-capita vaccination rates in Asia, with&nbsp;about 40%&nbsp;of the population having received their first dose. The Southeast Asian nation is&nbsp;allowing&nbsp;school children to be inoculated from this month, as part of its strategy to reopen the economy.</p>\n<p>The health ministry will release more details in the coming days and is also studying the possibility for private health-care institutions to access the stock of 200,000 doses. It is working out the details on pricing, informed consent process and safety of the patients who prefer this vaccine, it said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Allows Sinovac Vaccine After WHO Emergency Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Allows Sinovac Vaccine After WHO Emergency Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 20:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-02/singapore-allows-sinovac-vaccine-after-who-emergency-approval?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Singapore will allow the use of Sinovac Biotech Ltd.’s Covid-19 vaccine, after the World Health Organization approved the drug as part of its emergency use listing.\nThe move means the drug can be ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-02/singapore-allows-sinovac-vaccine-after-who-emergency-approval?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数","SVA":"科兴生物"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-02/singapore-allows-sinovac-vaccine-after-who-emergency-approval?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132140510","content_text":"Singapore will allow the use of Sinovac Biotech Ltd.’s Covid-19 vaccine, after the World Health Organization approved the drug as part of its emergency use listing.\nThe move means the drug can be administered by private health care providers as part of a program that allows the use of unregistered Covid-19 vaccines, the ministry of health said in a statement Wednesday. The Sinovac vaccine is not part of the national vaccine program.\nThe World Health Organization authorized the Sinovac vaccine on June 1, paving the way for a wider rollout in countriesscramblingfor a supply of immunizations. Singapore’s decision comes about three months after the country received its first shipment of 200,000 doses of the Sinovac shot on Feb. 23, and amid debate over the efficacy of the vaccine.\nThe shot, dubbed CoronaVac, has the lowest efficacy rate reported from clinical trials among the frontrunner wave of vaccines: it was found to be just 50.7% effective in preventing symptomatic Covid in a trial in Brazil, barely crossing the minimum threshold required by drug regulators around the world. But real world evidence is emerging that it’s far more effective on the ground: In a recent study of around 130,000 Indonesia health workers, it protected 94% against symptomatic infection, 96% against hospitalization, and 98% against death.\nSingapore has authorized both the Pfizer Inc.-BioNTech SE and Moderna Inc. vaccines, and has one of the best per-capita vaccination rates in Asia, with about 40% of the population having received their first dose. The Southeast Asian nation is allowing school children to be inoculated from this month, as part of its strategy to reopen the economy.\nThe health ministry will release more details in the coming days and is also studying the possibility for private health-care institutions to access the stock of 200,000 doses. It is working out the details on pricing, informed consent process and safety of the patients who prefer this vaccine, it said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":525,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113706732,"gmtCreate":1622638205926,"gmtModify":1704187800684,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/113706732","repostId":"1181132025","repostType":4,"isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355676579,"gmtCreate":1617071290091,"gmtModify":1704801562309,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Ermmm","listText":"Ermmm","text":"Ermmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/355676579","repostId":"2123607230","repostType":4,"isVote":1,"tweetType":1,"viewCount":577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355678676,"gmtCreate":1617071220495,"gmtModify":1704801561488,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"It is time to pay attention to Oil &amp; Gas","listText":"It is time to pay attention to Oil &amp; Gas","text":"It is time to pay attention to Oil & Gas","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/355678676","repostId":"2123926557","repostType":4,"repost":{"id":"2123926557","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617066000,"share":"https://ttm.financial/m/news/2123926557?lang=&edition=fundamental","pubTime":"2021-03-30 09:00","market":"fut","language":"en","title":"Oil prices hit by wave of hedge fund profit-taking: Kemp","url":"https://stock-news.laohu8.com/highlight/detail?id=2123926557","media":"Reuters","summary":"LONDON, March 29 (Reuters) - Fund managers sold petroleum last week at the fastest rate since succes","content":"<p>LONDON, March 29 (Reuters) - Fund managers sold petroleum last week at the fastest rate since successful coronavirus vaccines were announced in November, as a resurgence of infections and a loss of upward price momentum triggered profit-taking.</p><p>Hedge funds and other money managers sold the equivalent of 88 million barrels of petroleum futures and options in the week to March 23, the fastest rate of selling since Nov. 3, according to exchange and regulatory data.</p><p>The heaviest selling was concentrated in Brent (-51 million barrels) but there were also sales in NYMEX and ICE WTI (-21 million), U.S. gasoline (-4 million), U.S. diesel (-5 million) and European gasoil (-8 million).</p><p>Most of the sales were driven by the liquidation of existing bullish long positions (which were reduced by 73 million barrels) rather than the creation of new bearish short ones (just 16 million barrels of shorts were added).</p><p>Prior to the sell-off, portfolio managers' positions had become lopsided, with a net position of 913 million barrels, which was in the 83rd percentile for all weeks since 2013.</p><p>Long positions outnumbered short positions by a ratio of 5.5:1, in the 75th percentile for all weeks since 2013 ().</p><p>Since at least the start of 2015, similar lopsided positions have normally preceded a sharp reversal in the previous price trend.</p><p>With so many funds having already placed a bullish bet on the direction of oil prices, and few short positions left to be covered, the market had become vulnerable to any setback.</p><p>In fact, flat prices and calendar spreads had already stopped rising from the middle of February, signalling a loss of upward momentum.</p><p>The resurgence of infections in Europe, concerns about the speed of vaccine deployments, and the prospect of another delay to the resumption of international air travel proved enough to trigger a wave of profit-taking.</p><p>The recent bout of selling has skimmed some of the frothiness off the top of the market.</p><p>But the hedge fund community is still very bullish towards oil, with a net position of 824 million barrels (76th percentile) and long/short ratio of 4.75 (66th percentile), just slightly more cautious than a few weeks ago.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil prices hit by wave of hedge fund profit-taking: Kemp</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil prices hit by wave of hedge fund profit-taking: Kemp\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-30 09:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON, March 29 (Reuters) - Fund managers sold petroleum last week at the fastest rate since successful coronavirus vaccines were announced in November, as a resurgence of infections and a loss of upward price momentum triggered profit-taking.</p><p>Hedge funds and other money managers sold the equivalent of 88 million barrels of petroleum futures and options in the week to March 23, the fastest rate of selling since Nov. 3, according to exchange and regulatory data.</p><p>The heaviest selling was concentrated in Brent (-51 million barrels) but there were also sales in NYMEX and ICE WTI (-21 million), U.S. gasoline (-4 million), U.S. diesel (-5 million) and European gasoil (-8 million).</p><p>Most of the sales were driven by the liquidation of existing bullish long positions (which were reduced by 73 million barrels) rather than the creation of new bearish short ones (just 16 million barrels of shorts were added).</p><p>Prior to the sell-off, portfolio managers' positions had become lopsided, with a net position of 913 million barrels, which was in the 83rd percentile for all weeks since 2013.</p><p>Long positions outnumbered short positions by a ratio of 5.5:1, in the 75th percentile for all weeks since 2013 ().</p><p>Since at least the start of 2015, similar lopsided positions have normally preceded a sharp reversal in the previous price trend.</p><p>With so many funds having already placed a bullish bet on the direction of oil prices, and few short positions left to be covered, the market had become vulnerable to any setback.</p><p>In fact, flat prices and calendar spreads had already stopped rising from the middle of February, signalling a loss of upward momentum.</p><p>The resurgence of infections in Europe, concerns about the speed of vaccine deployments, and the prospect of another delay to the resumption of international air travel proved enough to trigger a wave of profit-taking.</p><p>The recent bout of selling has skimmed some of the frothiness off the top of the market.</p><p>But the hedge fund community is still very bullish towards oil, with a net position of 824 million barrels (76th percentile) and long/short ratio of 4.75 (66th percentile), just slightly more cautious than a few weeks ago.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/aa4a2187b267c2b09c55779e0a8af4ab","relate_stocks":{"DDG":"ProShares做空石油与天然气ETF","UCO":"二倍做多彭博原油ETF","USO":"美国原油ETF","DWT":"三倍做空原油ETN","SCO":"二倍做空彭博原油指数ETF","DUG":"二倍做空石油与天然气ETF(ProShares)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2123926557","content_text":"LONDON, March 29 (Reuters) - Fund managers sold petroleum last week at the fastest rate since successful coronavirus vaccines were announced in November, as a resurgence of infections and a loss of upward price momentum triggered profit-taking.Hedge funds and other money managers sold the equivalent of 88 million barrels of petroleum futures and options in the week to March 23, the fastest rate of selling since Nov. 3, according to exchange and regulatory data.The heaviest selling was concentrated in Brent (-51 million barrels) but there were also sales in NYMEX and ICE WTI (-21 million), U.S. gasoline (-4 million), U.S. diesel (-5 million) and European gasoil (-8 million).Most of the sales were driven by the liquidation of existing bullish long positions (which were reduced by 73 million barrels) rather than the creation of new bearish short ones (just 16 million barrels of shorts were added).Prior to the sell-off, portfolio managers' positions had become lopsided, with a net position of 913 million barrels, which was in the 83rd percentile for all weeks since 2013.Long positions outnumbered short positions by a ratio of 5.5:1, in the 75th percentile for all weeks since 2013 ().Since at least the start of 2015, similar lopsided positions have normally preceded a sharp reversal in the previous price trend.With so many funds having already placed a bullish bet on the direction of oil prices, and few short positions left to be covered, the market had become vulnerable to any setback.In fact, flat prices and calendar spreads had already stopped rising from the middle of February, signalling a loss of upward momentum.The resurgence of infections in Europe, concerns about the speed of vaccine deployments, and the prospect of another delay to the resumption of international air travel proved enough to trigger a wave of profit-taking.The recent bout of selling has skimmed some of the frothiness off the top of the market.But the hedge fund community is still very bullish towards oil, with a net position of 824 million barrels (76th percentile) and long/short ratio of 4.75 (66th percentile), just slightly more cautious than a few weeks ago.","news_type":1},"isVote":1,"tweetType":1,"viewCount":746,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355670111,"gmtCreate":1617070887233,"gmtModify":1704801556422,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Finally","listText":"Finally","text":"Finally","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/355670111","repostId":"2123266804","repostType":4,"repost":{"id":"2123266804","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617068669,"share":"https://ttm.financial/m/news/2123266804?lang=&edition=fundamental","pubTime":"2021-03-30 09:44","market":"fut","language":"en","title":"Oil prices slip as focus switches from Suez Canal blockage to OPEC+ supply policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2123266804","media":"Reuters","summary":"TOKYO, March 30 (Reuters) - Oil prices fell on Tuesday as shipping traffic resumed through the Suez ","content":"<p>TOKYO, March 30 (Reuters) - Oil prices fell on Tuesday as shipping traffic resumed through the Suez Canal after days on hold and attention switched to an OPEC+ meeting this week where the extension of supply curbs may be on the table amid new coronavirus pandemic lockdowns.</p>\n<p>Brent crude was down 15 cents, or 0.2%, at $64.83 a barrel by 0115 GMT, after gaining 0.6% on Monday. U.S. oil</p>\n<p>was down 1 cent at $61.55 a barrel, having fallen 1% in the previous session.</p>\n<p>Ships were moving through the Suez Canal again on Tuesday after tugs refloated the giant Ever Given container carrier, which had been blocking a narrow section of the passage for almost a week, causing a huge build-up of vessels around the waterway.</p>\n<p>With the likelihood that the disruption will prove minimal, the market is turning its focus to Thursday's meeting of the Organization of the Petroleum Exporting Countries (OPEC) and allies including Russia in Vienna, collectively known as OPEC+.</p>\n<p>They will discuss whether to keep in place curbs on output that have kept millions of barrels a day off the market to support prices, a strategy that has largely worked in recent months.</p>\n<p>Saudi Arabia is prepared to accept an extension of the production cuts through June, and is also ready to prolong voluntary unilateral curbs amid the latest wave of coronavirus lockdowns, a source briefed on the matter said on Monday.</p>\n<p>\"Market expectations for no change to output are largely priced in,\" said Howie Lee, economist at OCBC Bank in Singapore. The revival of heavy coronavirus caseloads in Europe \"has put a brake on oil's resurgence\".</p>\n<p>More than 127.43 million people have been reported to be infected by the novel coronavirus globally, and the death toll is approaching 3 million, according to a Reuters tally.</p>\n<p>In Europe, rising numbers in a third wave of infections are alarming authorities, with France's Finance Minister Bruno Le Maire saying \"all options are on the table\" to protect the public.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil prices slip as focus switches from Suez Canal blockage to OPEC+ supply policy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil prices slip as focus switches from Suez Canal blockage to OPEC+ supply policy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-30 09:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, March 30 (Reuters) - Oil prices fell on Tuesday as shipping traffic resumed through the Suez Canal after days on hold and attention switched to an OPEC+ meeting this week where the extension of supply curbs may be on the table amid new coronavirus pandemic lockdowns.</p>\n<p>Brent crude was down 15 cents, or 0.2%, at $64.83 a barrel by 0115 GMT, after gaining 0.6% on Monday. U.S. oil</p>\n<p>was down 1 cent at $61.55 a barrel, having fallen 1% in the previous session.</p>\n<p>Ships were moving through the Suez Canal again on Tuesday after tugs refloated the giant Ever Given container carrier, which had been blocking a narrow section of the passage for almost a week, causing a huge build-up of vessels around the waterway.</p>\n<p>With the likelihood that the disruption will prove minimal, the market is turning its focus to Thursday's meeting of the Organization of the Petroleum Exporting Countries (OPEC) and allies including Russia in Vienna, collectively known as OPEC+.</p>\n<p>They will discuss whether to keep in place curbs on output that have kept millions of barrels a day off the market to support prices, a strategy that has largely worked in recent months.</p>\n<p>Saudi Arabia is prepared to accept an extension of the production cuts through June, and is also ready to prolong voluntary unilateral curbs amid the latest wave of coronavirus lockdowns, a source briefed on the matter said on Monday.</p>\n<p>\"Market expectations for no change to output are largely priced in,\" said Howie Lee, economist at OCBC Bank in Singapore. The revival of heavy coronavirus caseloads in Europe \"has put a brake on oil's resurgence\".</p>\n<p>More than 127.43 million people have been reported to be infected by the novel coronavirus globally, and the death toll is approaching 3 million, according to a Reuters tally.</p>\n<p>In Europe, rising numbers in a third wave of infections are alarming authorities, with France's Finance Minister Bruno Le Maire saying \"all options are on the table\" to protect the public.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3faadc006e67e6ac130a7b171f263b4d","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2123266804","content_text":"TOKYO, March 30 (Reuters) - Oil prices fell on Tuesday as shipping traffic resumed through the Suez Canal after days on hold and attention switched to an OPEC+ meeting this week where the extension of supply curbs may be on the table amid new coronavirus pandemic lockdowns.\nBrent crude was down 15 cents, or 0.2%, at $64.83 a barrel by 0115 GMT, after gaining 0.6% on Monday. U.S. oil\nwas down 1 cent at $61.55 a barrel, having fallen 1% in the previous session.\nShips were moving through the Suez Canal again on Tuesday after tugs refloated the giant Ever Given container carrier, which had been blocking a narrow section of the passage for almost a week, causing a huge build-up of vessels around the waterway.\nWith the likelihood that the disruption will prove minimal, the market is turning its focus to Thursday's meeting of the Organization of the Petroleum Exporting Countries (OPEC) and allies including Russia in Vienna, collectively known as OPEC+.\nThey will discuss whether to keep in place curbs on output that have kept millions of barrels a day off the market to support prices, a strategy that has largely worked in recent months.\nSaudi Arabia is prepared to accept an extension of the production cuts through June, and is also ready to prolong voluntary unilateral curbs amid the latest wave of coronavirus lockdowns, a source briefed on the matter said on Monday.\n\"Market expectations for no change to output are largely priced in,\" said Howie Lee, economist at OCBC Bank in Singapore. The revival of heavy coronavirus caseloads in Europe \"has put a brake on oil's resurgence\".\nMore than 127.43 million people have been reported to be infected by the novel coronavirus globally, and the death toll is approaching 3 million, according to a Reuters tally.\nIn Europe, rising numbers in a third wave of infections are alarming authorities, with France's Finance Minister Bruno Le Maire saying \"all options are on the table\" to protect the public.","news_type":1},"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355647538,"gmtCreate":1617070844924,"gmtModify":1704801555444,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Alert","listText":"Alert","text":"Alert","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/355647538","repostId":"2123607230","repostType":4,"repost":{"id":"2123607230","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1617070299,"share":"https://ttm.financial/m/news/2123607230?lang=&edition=fundamental","pubTime":"2021-03-30 10:11","market":"us","language":"en","title":"Beware The 11 Most Overvalued Stocks Now, Analysts Warn","url":"https://stock-news.laohu8.com/highlight/detail?id=2123607230","media":"Investors","summary":"Analysts called the Tesla crash and the big tumble in video streamers' stocks. But their warnings are still going unheeded on a number of S&P 500 companies.","content":"<p>Analysts called the <b>Tesla</b> crash and the big tumble in video streamers' stocks. But their warnings are still going unheeded on a number of S&amp;P 500 companies.</p><p>Nearly a dozen S&amp;P 500 companies, including industrials <b>American Airlines</b> and <b>Snap-on</b> plus communications services <b><a href=\"https://laohu8.com/S/LUMN\">Lumen Technologies</a></b> are still grossly overvalued compared to analysts' 12-month price targets on the stocks, says an Investor's Business Daily analysis of data from S&amp;P Global Market Intelligence and MarketSmith.</p><p>By analysts' estimates, all 11 of these S&amp;P 500 stocks are at least 10% overvalued. And the warnings come amid big run-ups in most of them. Investors are piling into stocks thought to benefit from a stronger economy. The 11 stocks are up an average 28.2% this year, while the SPDR S&amp;P 500 ETF Trust is up just 5.9%. What's more, eight of the 11 are up 20% or more in 2021 so far.</p><p>Seeing analysts dig in with warnings of lower price targets amid a rally, especially in cyclical stocks, is noteworthy.</p><p><b>S&amp;P 500 Analysts Are Actually Bullish</b></p><p>Analysts have pounded the table warning of overvaluation of Tesla stock. And they also cautioned on shares of <b>ViacomCBS</b> and <b>Discovery</b> before they sold off.</p><p>But overall, analysts — like usual — are mostly bullish on S&amp;P 500 stocks. Analysts' 12-month price targets on the individual stocks in the S&amp;P 500 are 6.5% higher than Friday's closing prices.</p><p>And fundamentals back up the bullishness. Already this year, 60 companies told analysts their earnings in the current quarter will be better than they previously estimated, says John Butters, earnings analyst at Factset.</p><p>That's the highest number of S&amp;P 500 companies issuing positive guidance for a quarter since at least 2006. Only about half that many companies were so positive on the same quarter a year ago. And that in turn means analysts now think S&amp;P 500 companies' profit will jump 23.3% in the first quarter. They only saw a 15.8% jump in first quarter profit at the end of 2020.</p><p><b>But Analysts See Pockets Of Overvaluation</b></p><p>American Airlines is the S&amp;P 500 stock analysts think is way beyond where it should be. And it's easy to see why.</p><p>Just this year, the airline's shares soared 45.4% to 22.93 a share. New investors piled into the airline's shares, even though it lost roughly $9 billion in 2020 as the pandemic all but shut down air travel. Analysts see a comeback, sort of. American is expected to only lose roughly $4 billion, or $7.61 a share, in 2021. But profitability isn't seen until 2022.</p><p>As a result, analysts' 12-month price target on American is just 15.47 a share. If that's right, it means the stock is 33% overvalued. And it doesn't have strong enough fundamentals to hold it up, either. The company's IBD Composite Rating is just 45. Do you know what to look at before buying American's stock?</p><p>Also in the industrials sector, analysts think tool seller Snap-on ran up too far, as well. Shares are up more than 34% this year to 229.63.</p><p>Unlike American, Snap-on has the fundamentals to back it up.</p><p>It sports a Composite Rating of 88. Snap-on's adjusted profit per share is seen hitting $12.44 in 2021, up nearly 7% from 2020. But again, analysts think the bulls are getting carried away. After all, profit fell 5% in 2020. So analysts think the company is only worth 190.33 a share in 12 months, or 16% less than it's trading now.</p><p><b>Watch Out For S&amp;P 500 Dividend Darlings</b></p><p>High dividend payers in the S&amp;P 500 are setting the markets on fire. All eight of the top yielding stocks in the S&amp;P 500 are topping the index in 2021 so far. And that includes voice and data networking company, Lumen.</p><p>Lumen is known for its whopping 7.4% dividend yield. That's solid in a world when the S&amp;P 500 yields just 1.5%. But it's even more famous among investors this year for a 35% jump in its stock price to 13.16. It's not exactly a screamingly positive fundamental story, either. Profit per share rose 26.5% in 2020. But profit is seen dropping 6.5% in 2021.</p><p>Analysts just think it's not worth what investors are paying. They're calling for Lumen to trade for 10.78 a share in 12 months, or 18% less than it is now.</p><p>It goes without saying analysts aren't always right. They're often wrong. But their warnings this year on S&amp;P 500 high-flyers, though, have been spot on so worth at least listening to.</p><p><b>The Most Overvalued S&amp;P 500 Stocks: Analysts</b></p><table><thead><tr><th>Company</th><th>Symbol</th><th>Target Price*</th><th>Stock YTD % Ch.</th><th>Implied Downside*</th><th>Sector</th><th>Composite Rating</th></tr></thead><tbody><tr><td>American Airlines</td><td></td><td>15.47</td><td>45.4%</td><td><b>-32.5%</b></td><td>Industrials</td><td>45</td></tr><tr><td>Lumen Technologies</td><td></td><td>10.78</td><td>35.0%</td><td><b>-18.1%</b></td><td>Communication Services</td><td>61</td></tr><tr><td>Snap-on</td><td></td><td>190.33</td><td>34.2%</td><td><b>-17.1%</b></td><td>Industrials</td><td>88</td></tr><tr><td>Nucor</td><td></td><td>66.38</td><td>49.1%</td><td><b>-16.3%</b></td><td>Materials</td><td>97</td></tr><tr><td>Expeditors International of Washington</td><td></td><td>91.64</td><td>13.3%</td><td><b>-15.0%</b></td><td>Industrials</td><td>80</td></tr><tr><td>Franklin Resources</td><td></td><td>25.47</td><td>17.6%</td><td><b>-13.4%</b></td><td>Financials</td><td>79</td></tr><tr><td>Genuine Parts</td><td></td><td>104.33</td><td>18.0%</td><td><b>-12.0%</b></td><td>Consumer Discretionary</td><td>64</td></tr><tr><td>Whirlpool</td><td></td><td>196.44</td><td>23.6%</td><td><b>-11.9%</b></td><td>Consumer Discretionary</td><td>91</td></tr><tr><td>Iron Mountain</td><td></td><td>33.25</td><td>26.5%</td><td><b>-10.8%</b></td><td>Real Estate</td><td>70</td></tr><tr><td>Unum</td><td></td><td>24.73</td><td>20.8%</td><td><b>-10.8%</b></td><td>Financials</td><td>59</td></tr><tr><td>A. O. Smith</td><td></td><td>62.11</td><td>26.8%</td><td><b>-10.6%</b></td><td>Industrials</td><td>74</td></tr></tbody></table><h5>Sources: IBD, S&amp;P Global Market Intelligence, * — based on analysts' 12-month price target</h5>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beware The 11 Most Overvalued Stocks Now, Analysts Warn</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeware The 11 Most Overvalued Stocks Now, Analysts Warn\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-03-30 10:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Analysts called the <b>Tesla</b> crash and the big tumble in video streamers' stocks. But their warnings are still going unheeded on a number of S&amp;P 500 companies.</p><p>Nearly a dozen S&amp;P 500 companies, including industrials <b>American Airlines</b> and <b>Snap-on</b> plus communications services <b><a href=\"https://laohu8.com/S/LUMN\">Lumen Technologies</a></b> are still grossly overvalued compared to analysts' 12-month price targets on the stocks, says an Investor's Business Daily analysis of data from S&amp;P Global Market Intelligence and MarketSmith.</p><p>By analysts' estimates, all 11 of these S&amp;P 500 stocks are at least 10% overvalued. And the warnings come amid big run-ups in most of them. Investors are piling into stocks thought to benefit from a stronger economy. The 11 stocks are up an average 28.2% this year, while the SPDR S&amp;P 500 ETF Trust is up just 5.9%. What's more, eight of the 11 are up 20% or more in 2021 so far.</p><p>Seeing analysts dig in with warnings of lower price targets amid a rally, especially in cyclical stocks, is noteworthy.</p><p><b>S&amp;P 500 Analysts Are Actually Bullish</b></p><p>Analysts have pounded the table warning of overvaluation of Tesla stock. And they also cautioned on shares of <b>ViacomCBS</b> and <b>Discovery</b> before they sold off.</p><p>But overall, analysts — like usual — are mostly bullish on S&amp;P 500 stocks. Analysts' 12-month price targets on the individual stocks in the S&amp;P 500 are 6.5% higher than Friday's closing prices.</p><p>And fundamentals back up the bullishness. Already this year, 60 companies told analysts their earnings in the current quarter will be better than they previously estimated, says John Butters, earnings analyst at Factset.</p><p>That's the highest number of S&amp;P 500 companies issuing positive guidance for a quarter since at least 2006. Only about half that many companies were so positive on the same quarter a year ago. And that in turn means analysts now think S&amp;P 500 companies' profit will jump 23.3% in the first quarter. They only saw a 15.8% jump in first quarter profit at the end of 2020.</p><p><b>But Analysts See Pockets Of Overvaluation</b></p><p>American Airlines is the S&amp;P 500 stock analysts think is way beyond where it should be. And it's easy to see why.</p><p>Just this year, the airline's shares soared 45.4% to 22.93 a share. New investors piled into the airline's shares, even though it lost roughly $9 billion in 2020 as the pandemic all but shut down air travel. Analysts see a comeback, sort of. American is expected to only lose roughly $4 billion, or $7.61 a share, in 2021. But profitability isn't seen until 2022.</p><p>As a result, analysts' 12-month price target on American is just 15.47 a share. If that's right, it means the stock is 33% overvalued. And it doesn't have strong enough fundamentals to hold it up, either. The company's IBD Composite Rating is just 45. Do you know what to look at before buying American's stock?</p><p>Also in the industrials sector, analysts think tool seller Snap-on ran up too far, as well. Shares are up more than 34% this year to 229.63.</p><p>Unlike American, Snap-on has the fundamentals to back it up.</p><p>It sports a Composite Rating of 88. Snap-on's adjusted profit per share is seen hitting $12.44 in 2021, up nearly 7% from 2020. But again, analysts think the bulls are getting carried away. After all, profit fell 5% in 2020. So analysts think the company is only worth 190.33 a share in 12 months, or 16% less than it's trading now.</p><p><b>Watch Out For S&amp;P 500 Dividend Darlings</b></p><p>High dividend payers in the S&amp;P 500 are setting the markets on fire. All eight of the top yielding stocks in the S&amp;P 500 are topping the index in 2021 so far. And that includes voice and data networking company, Lumen.</p><p>Lumen is known for its whopping 7.4% dividend yield. That's solid in a world when the S&amp;P 500 yields just 1.5%. But it's even more famous among investors this year for a 35% jump in its stock price to 13.16. It's not exactly a screamingly positive fundamental story, either. Profit per share rose 26.5% in 2020. But profit is seen dropping 6.5% in 2021.</p><p>Analysts just think it's not worth what investors are paying. They're calling for Lumen to trade for 10.78 a share in 12 months, or 18% less than it is now.</p><p>It goes without saying analysts aren't always right. They're often wrong. But their warnings this year on S&amp;P 500 high-flyers, though, have been spot on so worth at least listening to.</p><p><b>The Most Overvalued S&amp;P 500 Stocks: Analysts</b></p><table><thead><tr><th>Company</th><th>Symbol</th><th>Target Price*</th><th>Stock YTD % Ch.</th><th>Implied Downside*</th><th>Sector</th><th>Composite Rating</th></tr></thead><tbody><tr><td>American Airlines</td><td></td><td>15.47</td><td>45.4%</td><td><b>-32.5%</b></td><td>Industrials</td><td>45</td></tr><tr><td>Lumen Technologies</td><td></td><td>10.78</td><td>35.0%</td><td><b>-18.1%</b></td><td>Communication Services</td><td>61</td></tr><tr><td>Snap-on</td><td></td><td>190.33</td><td>34.2%</td><td><b>-17.1%</b></td><td>Industrials</td><td>88</td></tr><tr><td>Nucor</td><td></td><td>66.38</td><td>49.1%</td><td><b>-16.3%</b></td><td>Materials</td><td>97</td></tr><tr><td>Expeditors International of Washington</td><td></td><td>91.64</td><td>13.3%</td><td><b>-15.0%</b></td><td>Industrials</td><td>80</td></tr><tr><td>Franklin Resources</td><td></td><td>25.47</td><td>17.6%</td><td><b>-13.4%</b></td><td>Financials</td><td>79</td></tr><tr><td>Genuine Parts</td><td></td><td>104.33</td><td>18.0%</td><td><b>-12.0%</b></td><td>Consumer Discretionary</td><td>64</td></tr><tr><td>Whirlpool</td><td></td><td>196.44</td><td>23.6%</td><td><b>-11.9%</b></td><td>Consumer Discretionary</td><td>91</td></tr><tr><td>Iron Mountain</td><td></td><td>33.25</td><td>26.5%</td><td><b>-10.8%</b></td><td>Real Estate</td><td>70</td></tr><tr><td>Unum</td><td></td><td>24.73</td><td>20.8%</td><td><b>-10.8%</b></td><td>Financials</td><td>59</td></tr><tr><td>A. O. Smith</td><td></td><td>62.11</td><td>26.8%</td><td><b>-10.6%</b></td><td>Industrials</td><td>74</td></tr></tbody></table><h5>Sources: IBD, S&amp;P Global Market Intelligence, * — based on analysts' 12-month price target</h5>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/9fa7c522340c9f1e78e78f0c1543440e","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares","SH":"标普500反向ETF","SPY":"标普500ETF","SSO":"两倍做多标普500ETF","SPXU":"三倍做空标普500ETF","SDS":"两倍做空标普500ETF","IVV":"标普500指数ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2123607230","content_text":"Analysts called the Tesla crash and the big tumble in video streamers' stocks. But their warnings are still going unheeded on a number of S&P 500 companies.Nearly a dozen S&P 500 companies, including industrials American Airlines and Snap-on plus communications services Lumen Technologies are still grossly overvalued compared to analysts' 12-month price targets on the stocks, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.By analysts' estimates, all 11 of these S&P 500 stocks are at least 10% overvalued. And the warnings come amid big run-ups in most of them. Investors are piling into stocks thought to benefit from a stronger economy. The 11 stocks are up an average 28.2% this year, while the SPDR S&P 500 ETF Trust is up just 5.9%. What's more, eight of the 11 are up 20% or more in 2021 so far.Seeing analysts dig in with warnings of lower price targets amid a rally, especially in cyclical stocks, is noteworthy.S&P 500 Analysts Are Actually BullishAnalysts have pounded the table warning of overvaluation of Tesla stock. And they also cautioned on shares of ViacomCBS and Discovery before they sold off.But overall, analysts — like usual — are mostly bullish on S&P 500 stocks. Analysts' 12-month price targets on the individual stocks in the S&P 500 are 6.5% higher than Friday's closing prices.And fundamentals back up the bullishness. Already this year, 60 companies told analysts their earnings in the current quarter will be better than they previously estimated, says John Butters, earnings analyst at Factset.That's the highest number of S&P 500 companies issuing positive guidance for a quarter since at least 2006. Only about half that many companies were so positive on the same quarter a year ago. And that in turn means analysts now think S&P 500 companies' profit will jump 23.3% in the first quarter. They only saw a 15.8% jump in first quarter profit at the end of 2020.But Analysts See Pockets Of OvervaluationAmerican Airlines is the S&P 500 stock analysts think is way beyond where it should be. And it's easy to see why.Just this year, the airline's shares soared 45.4% to 22.93 a share. New investors piled into the airline's shares, even though it lost roughly $9 billion in 2020 as the pandemic all but shut down air travel. Analysts see a comeback, sort of. American is expected to only lose roughly $4 billion, or $7.61 a share, in 2021. But profitability isn't seen until 2022.As a result, analysts' 12-month price target on American is just 15.47 a share. If that's right, it means the stock is 33% overvalued. And it doesn't have strong enough fundamentals to hold it up, either. The company's IBD Composite Rating is just 45. Do you know what to look at before buying American's stock?Also in the industrials sector, analysts think tool seller Snap-on ran up too far, as well. Shares are up more than 34% this year to 229.63.Unlike American, Snap-on has the fundamentals to back it up.It sports a Composite Rating of 88. Snap-on's adjusted profit per share is seen hitting $12.44 in 2021, up nearly 7% from 2020. But again, analysts think the bulls are getting carried away. After all, profit fell 5% in 2020. So analysts think the company is only worth 190.33 a share in 12 months, or 16% less than it's trading now.Watch Out For S&P 500 Dividend DarlingsHigh dividend payers in the S&P 500 are setting the markets on fire. All eight of the top yielding stocks in the S&P 500 are topping the index in 2021 so far. And that includes voice and data networking company, Lumen.Lumen is known for its whopping 7.4% dividend yield. That's solid in a world when the S&P 500 yields just 1.5%. But it's even more famous among investors this year for a 35% jump in its stock price to 13.16. It's not exactly a screamingly positive fundamental story, either. Profit per share rose 26.5% in 2020. But profit is seen dropping 6.5% in 2021.Analysts just think it's not worth what investors are paying. They're calling for Lumen to trade for 10.78 a share in 12 months, or 18% less than it is now.It goes without saying analysts aren't always right. They're often wrong. But their warnings this year on S&P 500 high-flyers, though, have been spot on so worth at least listening to.The Most Overvalued S&P 500 Stocks: AnalystsCompanySymbolTarget Price*Stock YTD % Ch.Implied Downside*SectorComposite RatingAmerican Airlines15.4745.4%-32.5%Industrials45Lumen Technologies10.7835.0%-18.1%Communication Services61Snap-on190.3334.2%-17.1%Industrials88Nucor66.3849.1%-16.3%Materials97Expeditors International of Washington91.6413.3%-15.0%Industrials80Franklin Resources25.4717.6%-13.4%Financials79Genuine Parts104.3318.0%-12.0%Consumer Discretionary64Whirlpool196.4423.6%-11.9%Consumer Discretionary91Iron Mountain33.2526.5%-10.8%Real Estate70Unum24.7320.8%-10.8%Financials59A. O. Smith62.1126.8%-10.6%Industrials74Sources: IBD, S&P Global Market Intelligence, * — based on analysts' 12-month price target","news_type":1},"isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":810235187,"gmtCreate":1629979573749,"gmtModify":1676530190421,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/810235187","repostId":"2162099674","repostType":4,"repost":{"id":"2162099674","kind":"highlight","pubTimestamp":1629979338,"share":"https://ttm.financial/m/news/2162099674?lang=&edition=fundamental","pubTime":"2021-08-26 20:02","market":"us","language":"en","title":"Open-Minded? Buy This Game-Changing Psychedelics Stock Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2162099674","media":"Motley Fool","summary":"Excellent investing opportunities frequently seem outlandish.","content":"<p>When it comes to investing, open-mindedness is a virtue. Entertaining ideas outside the mainstream means you'll find opportunities that other people might reject or fail to recognize. In this vein, open-minded investors should definitely be watching the psychedelic therapy space very closely, because <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its leaders is on the cusp of something wonderful.</p>\n<p><b><a href=\"https://laohu8.com/S/CMPS\">COMPASS Pathways plc</a> </b>(NASDAQ:CMPS) will likely be the first healthcare company to bring a psychedelic therapy to market. While its business model relies on in-person clinical sessions that may be costly to administer, it's also one of the few psychedelics companies that has a plethora of opportunities to upsell patients on value-added services. And its much-vaunted training program for therapists could make it a key upstream supplier of skilled and credentialed labor for the rest of the psychedelics industry for years to come. Let's take a closer look at why these two tidbits make it a game-changing stock.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640413%2Ftherapist-talks-with-patient-sitting-on-a-couch.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>An innovative approach makes for more opportunities to find value</h2>\n<p>Compass' lead program for treatment-resistant depression, COMP360, isn't a typical biotech project.</p>\n<p>COMP360 is the combination of the psychedelic drug psilocybin and several sessions of psychological support from trained practitioners. The therapy is in phase 2b of clinical trials, and it's currently the world's largest clinical trial of psilocybin for any indication. It's also a bit complicated, so let's take a moment to understand how it works.</p>\n<p>First, therapists prepare patients for their psychedelic experience with the help of the company's automated education platform. Then, they guide the patients through a talking therapy routine while they're under the drug's hallucinogenic effects, which last for around seven hours. All the while, patients rest comfortably in Compass' specially designed therapy rooms. Finally, the therapists help patients to build on their progress with more discussion sessions in the weeks after the psilocybin treatment.</p>\n<p>Compass is the only psychedelic company that's using its training program for therapists as a major center of value generation. Its curriculum includes supervised hands-on practice in cooperation with academic institutions, and improvements are constantly being made based on data from clinical trials.</p>\n<p>Having a training regimen is incredibly valuable, as it's part of the package which Compass will submit to regulators to prove that COMP360 is safe and effective. If the therapy is approved for sale, the training curriculum will become the first of its kind, and it's realistic to think competitors might want to license it to train their personnel. What's more, the company's curriculum could become a sought-after credential among mental health practitioners if and when psychedelic therapies become ever more common.</p>\n<p>The business's other major value-adding innovation is its control of the therapeutic environment. Compass' therapy rooms are designed to support therapeutic outcomes by providing a pleasant but neutral setting, thereby reducing the chance that a patient has a difficult experience. To my knowledge, no other psychedelic medicine company is taking this key factor into account as seriously as Compass. As a result, it has developed what may be a powerful force multiplier and important safety feature for its treatment. That'll support COMP360's efficacy in the clinic, and it'll also give the company the opportunity to command a significantly higher price once regulators have given the go-ahead.</p>\n<h2>You might need to wait awhile to see returns</h2>\n<p>One important thing to know about Compass' stock is that it'll be at least a couple of years before its revenue starts to grow from administering its therapies, assuming they get regulatory approval. Another issue is that psilocybin is still heavily restricted and illegal at the federal level in the U.S., though a few jurisdictions have made some exceptions. So, there's a risk that COMP360 never makes it to the market if the legal landscape remains inflexible.</p>\n<p>Nonetheless, there are still a few upcoming catalysts which could make the stock worth owning in the short term. Before the end of the year, the company should report the full data from its phase 2b clinical trial. If the readout is favorable, expect the stock to jump in anticipation of the commencement of the final phase of the development process. Even if the data isn't what investors were hoping for, it might provide another good opportunity to buy the stock.</p>\n<p>Compass is also investigating in preclinical studies a smattering of conditions for which its lead candidate might also be effective, including Alzheimer's disease, chronic pain, epilepsy, and autism spectrum disorders. Given its favorable efficacy so far, it'd be surprising if there wasn't at least one other promising indication to move forward into clinical trials over the next couple of years.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Open-Minded? Buy This Game-Changing Psychedelics Stock Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpen-Minded? Buy This Game-Changing Psychedelics Stock Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 20:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/26/open-minded-buy-this-game-changing-psychedelics-st/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When it comes to investing, open-mindedness is a virtue. Entertaining ideas outside the mainstream means you'll find opportunities that other people might reject or fail to recognize. In this vein, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/26/open-minded-buy-this-game-changing-psychedelics-st/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CMPS":"COMPASS Pathways plc"},"source_url":"https://www.fool.com/investing/2021/08/26/open-minded-buy-this-game-changing-psychedelics-st/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162099674","content_text":"When it comes to investing, open-mindedness is a virtue. Entertaining ideas outside the mainstream means you'll find opportunities that other people might reject or fail to recognize. In this vein, open-minded investors should definitely be watching the psychedelic therapy space very closely, because one of its leaders is on the cusp of something wonderful.\nCOMPASS Pathways plc (NASDAQ:CMPS) will likely be the first healthcare company to bring a psychedelic therapy to market. While its business model relies on in-person clinical sessions that may be costly to administer, it's also one of the few psychedelics companies that has a plethora of opportunities to upsell patients on value-added services. And its much-vaunted training program for therapists could make it a key upstream supplier of skilled and credentialed labor for the rest of the psychedelics industry for years to come. Let's take a closer look at why these two tidbits make it a game-changing stock.\n\nImage source: Getty Images.\nAn innovative approach makes for more opportunities to find value\nCompass' lead program for treatment-resistant depression, COMP360, isn't a typical biotech project.\nCOMP360 is the combination of the psychedelic drug psilocybin and several sessions of psychological support from trained practitioners. The therapy is in phase 2b of clinical trials, and it's currently the world's largest clinical trial of psilocybin for any indication. It's also a bit complicated, so let's take a moment to understand how it works.\nFirst, therapists prepare patients for their psychedelic experience with the help of the company's automated education platform. Then, they guide the patients through a talking therapy routine while they're under the drug's hallucinogenic effects, which last for around seven hours. All the while, patients rest comfortably in Compass' specially designed therapy rooms. Finally, the therapists help patients to build on their progress with more discussion sessions in the weeks after the psilocybin treatment.\nCompass is the only psychedelic company that's using its training program for therapists as a major center of value generation. Its curriculum includes supervised hands-on practice in cooperation with academic institutions, and improvements are constantly being made based on data from clinical trials.\nHaving a training regimen is incredibly valuable, as it's part of the package which Compass will submit to regulators to prove that COMP360 is safe and effective. If the therapy is approved for sale, the training curriculum will become the first of its kind, and it's realistic to think competitors might want to license it to train their personnel. What's more, the company's curriculum could become a sought-after credential among mental health practitioners if and when psychedelic therapies become ever more common.\nThe business's other major value-adding innovation is its control of the therapeutic environment. Compass' therapy rooms are designed to support therapeutic outcomes by providing a pleasant but neutral setting, thereby reducing the chance that a patient has a difficult experience. To my knowledge, no other psychedelic medicine company is taking this key factor into account as seriously as Compass. As a result, it has developed what may be a powerful force multiplier and important safety feature for its treatment. That'll support COMP360's efficacy in the clinic, and it'll also give the company the opportunity to command a significantly higher price once regulators have given the go-ahead.\nYou might need to wait awhile to see returns\nOne important thing to know about Compass' stock is that it'll be at least a couple of years before its revenue starts to grow from administering its therapies, assuming they get regulatory approval. Another issue is that psilocybin is still heavily restricted and illegal at the federal level in the U.S., though a few jurisdictions have made some exceptions. So, there's a risk that COMP360 never makes it to the market if the legal landscape remains inflexible.\nNonetheless, there are still a few upcoming catalysts which could make the stock worth owning in the short term. Before the end of the year, the company should report the full data from its phase 2b clinical trial. If the readout is favorable, expect the stock to jump in anticipation of the commencement of the final phase of the development process. Even if the data isn't what investors were hoping for, it might provide another good opportunity to buy the stock.\nCompass is also investigating in preclinical studies a smattering of conditions for which its lead candidate might also be effective, including Alzheimer's disease, chronic pain, epilepsy, and autism spectrum disorders. Given its favorable efficacy so far, it'd be surprising if there wasn't at least one other promising indication to move forward into clinical trials over the next couple of years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":817,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574771607647825","authorId":"3574771607647825","name":"Eellen","avatar":"https://static.tigerbbs.com/0cbc0a268b9b34bfdb5dbf82ce98d474","crmLevel":3,"crmLevelSwitch":1,"idStr":"3574771607647825","authorIdStr":"3574771607647825"},"content":"Like and comment","text":"Like and comment","html":"Like and comment"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113706732,"gmtCreate":1622638205926,"gmtModify":1704187800684,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/113706732","repostId":"1181132025","repostType":4,"repost":{"id":"1181132025","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622636387,"share":"https://ttm.financial/m/news/1181132025?lang=&edition=fundamental","pubTime":"2021-06-02 20:19","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1181132025","media":"Tiger Newspress","summary":"S&P futures flat as investors bide time until key economic reportsAMC led 'meme stocks' higher again","content":"<ul><li>S&amp;P futures flat as investors bide time until key economic reports</li></ul><ul><li>AMC led 'meme stocks' higher again</li></ul><p>The latest leg of a surge in so-called \"meme stocks\" stood out in early moves on Wall Street on Wednesday, while futures tracking the main stock indexes were broadly flat ahead of closely watched economic data this week.</p><p>At 8:10 a.m. ET, Dow e-minis were up 29 points, or 0.08%, S&amp;P 500 e-minis were up 1.25 points, or 0.03%, and Nasdaq 100 e-minis were down 3.75 points, or 0.03%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62983bd4f06e2229211aece573ee8ed9\" tg-width=\"1080\" tg-height=\"391\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:10</span></p><p>AMC Entertainment Holdings Inc&nbsp;surged 23% to $40 in premarket trading, eyeing a record high with its stock trading 11 times analysts' median target price.</p><p>Later in the day, investors will turn to the Fed's Beige Book report, which will give a glimpse of the state of the economy based on conversations with business contacts.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><b>AMC Entertainment&nbsp;(AMC)</b> – AMC surged 23.7% in premarket trading following yesterday’s 22.7% jump. That came after the movie theater operator raised more than $230 million in a share sale to hedge fund Mudrick Capital, which is said to have immediately sold those shares at a profit.</p><p><b>BlackBerry&nbsp;(BB)</b>&nbsp;–&nbsp;BlackBerry's U.S.-listed shares rose about 20% in pre-market trading, bringing their total yearly gains to more than 75%.</p><p><b>Zoom Video&nbsp;(ZM)</b> – Zoom came in 33 cents a share ahead of estimates, with quarterly earnings of $1.33 per share. The video communications platform company’s revenue beat analysts’ forecasts as well, and the company gave upbeat guidance even as more people return to offices. Zoom shares gained 0.6% in the premarket.</p><p><b>Tesla&nbsp;(TSLA)</b> – Tesla was reportedly told by the Securities and Exchange Commission, once in 2019 and once in 2020, that it had failed to properly approve tweets by CEO Elon Musk on two occasions. The Wall Street Journal cited documents obtained under the Freedom of Information Act, which point to one tweet about Tesla’s stock price and another about production levels.</p><p><b>Etsy&nbsp;(ETSY) </b>– The online crafts marketplace announced&nbsp;a deal to buy fashion resale company Depop&nbsp;for $1.625 billion. London-based Depop will continue to operate as a separate marketplace after the deal is completed. Etsy rose 1% in the premarket.</p><p><b>Taiwan Semiconductor&nbsp;(TSM)</b> – The chip maker has begun construction at a new chip plant in Arizona, according to Chief Executive Officer C.C. Wei. He said the planned factory remains on track to begin chip production in 2024.</p><p><b>RLX Technology&nbsp;(RLX)</b>&nbsp;–&nbsp;RLX Technology reported&nbsp;Q1 revenues $366.1 million,up 48.2% YOY;Non-GAAP net income&nbsp;was&nbsp;$93.2 million, up 45.6% YOY.The&nbsp;shares&nbsp;surged&nbsp;9%&nbsp;in premarket trading.</p><p><b>Moderna&nbsp;(MRNA)</b> – The drugmaker announced a partnership with life sciences company&nbsp;Thermo Fisher Scientific&nbsp;(TMO) to provide manufacturing and packaging services for Moderna’s Covid-19 vaccine as it seeks to ramp up production.</p><p><b>Lands’ End&nbsp;(LE)</b> – The apparel retailer reported an unexpected profit of 8 cents per share, compared to a consensus forecast for a 29 cents per share quarterly loss. Revenue also exceeded estimates, helped by a jump in digital sales. Lands’ End surged 6.6% in premarket trading.</p><p><b>Ambarella&nbsp;(AMBA) </b>– Ambarella beat estimates by 6 cents a share, with quarterly profit of 23 cents per share. The maker of video chips and components also saw its revenue beat Street projections, boosted by strong growth in the company’s automotive business. It also gave an upbeat outlook. Ambarella rallied 4.9% in the premarket.</p><p><b>Advance Auto Parts&nbsp;(AAP)</b> – The auto parts retailer earned $3.34 per share for its latest quarter, beating the consensus estimate of $3.08 a share. Revenue came in above estimates as well. Comparable-store sales increased 24.7%, slightly better than the 23% consensus estimate. Advance Auto noted sales strength from both do-it-yourself and professional customers.</p><p><b>Hewlett Packard Enterprise</b>&nbsp;<b>(HPE)</b> – Hewlett Packard Enterprise reported a quarterly profit of 46 cents per share, beating estimates by 4 cents a share. Revenue also topped Wall Street forecasts. The enterprise computing company posted its first year-over-year revenue growth since 2018, however it also reported a sequential decline in hardware profit margins. Its shares fell 1.8% in premarket trading.</p><p><b>Cinemark&nbsp;(CNK),IMAX&nbsp;(IMAX) </b>– Goldman Sachs downgraded both stocks to “sell” from “neutral,” saying an expected movie box office recovery in 2021 and 2022 is already reflected in the prices of both stocks and that there are “heightened risks” to that recovery. Cinemark lost 2.8% in premarket action, while IMAX fell 2.5%</p><p><b>Scotts Miracle-Gro&nbsp;(SMG)</b> – Scotts raised its full-year financial outlook, as it expects the pandemic-related boost in sales of lawn and garden products to continue even as the pandemic recedes. Scotts now expects full-year sales growth of 17% to 19%, compared to a prior estimate of 8% to 12%. Scotts shares added 1% in premarket action.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-02 20:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>S&amp;P futures flat as investors bide time until key economic reports</li></ul><ul><li>AMC led 'meme stocks' higher again</li></ul><p>The latest leg of a surge in so-called \"meme stocks\" stood out in early moves on Wall Street on Wednesday, while futures tracking the main stock indexes were broadly flat ahead of closely watched economic data this week.</p><p>At 8:10 a.m. ET, Dow e-minis were up 29 points, or 0.08%, S&amp;P 500 e-minis were up 1.25 points, or 0.03%, and Nasdaq 100 e-minis were down 3.75 points, or 0.03%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62983bd4f06e2229211aece573ee8ed9\" tg-width=\"1080\" tg-height=\"391\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:10</span></p><p>AMC Entertainment Holdings Inc&nbsp;surged 23% to $40 in premarket trading, eyeing a record high with its stock trading 11 times analysts' median target price.</p><p>Later in the day, investors will turn to the Fed's Beige Book report, which will give a glimpse of the state of the economy based on conversations with business contacts.</p><p><b>Stocks making the biggest moves in the premarket:</b></p><p><b>AMC Entertainment&nbsp;(AMC)</b> – AMC surged 23.7% in premarket trading following yesterday’s 22.7% jump. That came after the movie theater operator raised more than $230 million in a share sale to hedge fund Mudrick Capital, which is said to have immediately sold those shares at a profit.</p><p><b>BlackBerry&nbsp;(BB)</b>&nbsp;–&nbsp;BlackBerry's U.S.-listed shares rose about 20% in pre-market trading, bringing their total yearly gains to more than 75%.</p><p><b>Zoom Video&nbsp;(ZM)</b> – Zoom came in 33 cents a share ahead of estimates, with quarterly earnings of $1.33 per share. The video communications platform company’s revenue beat analysts’ forecasts as well, and the company gave upbeat guidance even as more people return to offices. Zoom shares gained 0.6% in the premarket.</p><p><b>Tesla&nbsp;(TSLA)</b> – Tesla was reportedly told by the Securities and Exchange Commission, once in 2019 and once in 2020, that it had failed to properly approve tweets by CEO Elon Musk on two occasions. The Wall Street Journal cited documents obtained under the Freedom of Information Act, which point to one tweet about Tesla’s stock price and another about production levels.</p><p><b>Etsy&nbsp;(ETSY) </b>– The online crafts marketplace announced&nbsp;a deal to buy fashion resale company Depop&nbsp;for $1.625 billion. London-based Depop will continue to operate as a separate marketplace after the deal is completed. Etsy rose 1% in the premarket.</p><p><b>Taiwan Semiconductor&nbsp;(TSM)</b> – The chip maker has begun construction at a new chip plant in Arizona, according to Chief Executive Officer C.C. Wei. He said the planned factory remains on track to begin chip production in 2024.</p><p><b>RLX Technology&nbsp;(RLX)</b>&nbsp;–&nbsp;RLX Technology reported&nbsp;Q1 revenues $366.1 million,up 48.2% YOY;Non-GAAP net income&nbsp;was&nbsp;$93.2 million, up 45.6% YOY.The&nbsp;shares&nbsp;surged&nbsp;9%&nbsp;in premarket trading.</p><p><b>Moderna&nbsp;(MRNA)</b> – The drugmaker announced a partnership with life sciences company&nbsp;Thermo Fisher Scientific&nbsp;(TMO) to provide manufacturing and packaging services for Moderna’s Covid-19 vaccine as it seeks to ramp up production.</p><p><b>Lands’ End&nbsp;(LE)</b> – The apparel retailer reported an unexpected profit of 8 cents per share, compared to a consensus forecast for a 29 cents per share quarterly loss. Revenue also exceeded estimates, helped by a jump in digital sales. Lands’ End surged 6.6% in premarket trading.</p><p><b>Ambarella&nbsp;(AMBA) </b>– Ambarella beat estimates by 6 cents a share, with quarterly profit of 23 cents per share. The maker of video chips and components also saw its revenue beat Street projections, boosted by strong growth in the company’s automotive business. It also gave an upbeat outlook. Ambarella rallied 4.9% in the premarket.</p><p><b>Advance Auto Parts&nbsp;(AAP)</b> – The auto parts retailer earned $3.34 per share for its latest quarter, beating the consensus estimate of $3.08 a share. Revenue came in above estimates as well. Comparable-store sales increased 24.7%, slightly better than the 23% consensus estimate. Advance Auto noted sales strength from both do-it-yourself and professional customers.</p><p><b>Hewlett Packard Enterprise</b>&nbsp;<b>(HPE)</b> – Hewlett Packard Enterprise reported a quarterly profit of 46 cents per share, beating estimates by 4 cents a share. Revenue also topped Wall Street forecasts. The enterprise computing company posted its first year-over-year revenue growth since 2018, however it also reported a sequential decline in hardware profit margins. Its shares fell 1.8% in premarket trading.</p><p><b>Cinemark&nbsp;(CNK),IMAX&nbsp;(IMAX) </b>– Goldman Sachs downgraded both stocks to “sell” from “neutral,” saying an expected movie box office recovery in 2021 and 2022 is already reflected in the prices of both stocks and that there are “heightened risks” to that recovery. Cinemark lost 2.8% in premarket action, while IMAX fell 2.5%</p><p><b>Scotts Miracle-Gro&nbsp;(SMG)</b> – Scotts raised its full-year financial outlook, as it expects the pandemic-related boost in sales of lawn and garden products to continue even as the pandemic recedes. Scotts now expects full-year sales growth of 17% to 19%, compared to a prior estimate of 8% to 12%. Scotts shares added 1% in premarket action.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","AMC":"AMC院线","ETSY":"Etsy, Inc.",".IXIC":"NASDAQ Composite","TSM":"台积电","RLX":"雾芯科技","MRNA":"Moderna, Inc.",".SPX":"S&P 500 Index","BB":"黑莓",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181132025","content_text":"S&P futures flat as investors bide time until key economic reportsAMC led 'meme stocks' higher againThe latest leg of a surge in so-called \"meme stocks\" stood out in early moves on Wall Street on Wednesday, while futures tracking the main stock indexes were broadly flat ahead of closely watched economic data this week.At 8:10 a.m. ET, Dow e-minis were up 29 points, or 0.08%, S&P 500 e-minis were up 1.25 points, or 0.03%, and Nasdaq 100 e-minis were down 3.75 points, or 0.03%.*Source From Tiger Trade, EST 08:10AMC Entertainment Holdings Inc surged 23% to $40 in premarket trading, eyeing a record high with its stock trading 11 times analysts' median target price.Later in the day, investors will turn to the Fed's Beige Book report, which will give a glimpse of the state of the economy based on conversations with business contacts.Stocks making the biggest moves in the premarket:AMC Entertainment (AMC) – AMC surged 23.7% in premarket trading following yesterday’s 22.7% jump. That came after the movie theater operator raised more than $230 million in a share sale to hedge fund Mudrick Capital, which is said to have immediately sold those shares at a profit.BlackBerry (BB) – BlackBerry's U.S.-listed shares rose about 20% in pre-market trading, bringing their total yearly gains to more than 75%.Zoom Video (ZM) – Zoom came in 33 cents a share ahead of estimates, with quarterly earnings of $1.33 per share. The video communications platform company’s revenue beat analysts’ forecasts as well, and the company gave upbeat guidance even as more people return to offices. Zoom shares gained 0.6% in the premarket.Tesla (TSLA) – Tesla was reportedly told by the Securities and Exchange Commission, once in 2019 and once in 2020, that it had failed to properly approve tweets by CEO Elon Musk on two occasions. The Wall Street Journal cited documents obtained under the Freedom of Information Act, which point to one tweet about Tesla’s stock price and another about production levels.Etsy (ETSY) – The online crafts marketplace announced a deal to buy fashion resale company Depop for $1.625 billion. London-based Depop will continue to operate as a separate marketplace after the deal is completed. Etsy rose 1% in the premarket.Taiwan Semiconductor (TSM) – The chip maker has begun construction at a new chip plant in Arizona, according to Chief Executive Officer C.C. Wei. He said the planned factory remains on track to begin chip production in 2024.RLX Technology (RLX) – RLX Technology reported Q1 revenues $366.1 million,up 48.2% YOY;Non-GAAP net income was $93.2 million, up 45.6% YOY.The shares surged 9% in premarket trading.Moderna (MRNA) – The drugmaker announced a partnership with life sciences company Thermo Fisher Scientific (TMO) to provide manufacturing and packaging services for Moderna’s Covid-19 vaccine as it seeks to ramp up production.Lands’ End (LE) – The apparel retailer reported an unexpected profit of 8 cents per share, compared to a consensus forecast for a 29 cents per share quarterly loss. Revenue also exceeded estimates, helped by a jump in digital sales. Lands’ End surged 6.6% in premarket trading.Ambarella (AMBA) – Ambarella beat estimates by 6 cents a share, with quarterly profit of 23 cents per share. The maker of video chips and components also saw its revenue beat Street projections, boosted by strong growth in the company’s automotive business. It also gave an upbeat outlook. Ambarella rallied 4.9% in the premarket.Advance Auto Parts (AAP) – The auto parts retailer earned $3.34 per share for its latest quarter, beating the consensus estimate of $3.08 a share. Revenue came in above estimates as well. Comparable-store sales increased 24.7%, slightly better than the 23% consensus estimate. Advance Auto noted sales strength from both do-it-yourself and professional customers.Hewlett Packard Enterprise (HPE) – Hewlett Packard Enterprise reported a quarterly profit of 46 cents per share, beating estimates by 4 cents a share. Revenue also topped Wall Street forecasts. The enterprise computing company posted its first year-over-year revenue growth since 2018, however it also reported a sequential decline in hardware profit margins. Its shares fell 1.8% in premarket trading.Cinemark (CNK),IMAX (IMAX) – Goldman Sachs downgraded both stocks to “sell” from “neutral,” saying an expected movie box office recovery in 2021 and 2022 is already reflected in the prices of both stocks and that there are “heightened risks” to that recovery. Cinemark lost 2.8% in premarket action, while IMAX fell 2.5%Scotts Miracle-Gro (SMG) – Scotts raised its full-year financial outlook, as it expects the pandemic-related boost in sales of lawn and garden products to continue even as the pandemic recedes. Scotts now expects full-year sales growth of 17% to 19%, compared to a prior estimate of 8% to 12%. Scotts shares added 1% in premarket action.","news_type":1},"isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113702277,"gmtCreate":1622638243499,"gmtModify":1704187801818,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/113702277","repostId":"1132140510","repostType":4,"isVote":1,"tweetType":1,"viewCount":525,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355670111,"gmtCreate":1617070887233,"gmtModify":1704801556422,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Finally","listText":"Finally","text":"Finally","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/355670111","repostId":"2123266804","repostType":4,"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355647538,"gmtCreate":1617070844924,"gmtModify":1704801555444,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Alert","listText":"Alert","text":"Alert","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/355647538","repostId":"2123607230","repostType":4,"isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355676579,"gmtCreate":1617071290091,"gmtModify":1704801562309,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"Ermmm","listText":"Ermmm","text":"Ermmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/355676579","repostId":"2123607230","repostType":4,"isVote":1,"tweetType":1,"viewCount":577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355678676,"gmtCreate":1617071220495,"gmtModify":1704801561488,"author":{"id":"3574939326528857","authorId":"3574939326528857","name":"Terryson","avatar":"https://static.tigerbbs.com/12b949c5530b63861ba1770060751b3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574939326528857","authorIdStr":"3574939326528857"},"themes":[],"htmlText":"It is time to pay attention to Oil &amp; Gas","listText":"It is time to pay attention to Oil &amp; Gas","text":"It is time to pay attention to Oil & Gas","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/355678676","repostId":"2123926557","repostType":4,"isVote":1,"tweetType":1,"viewCount":746,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}